Skip to main content
Erschienen in: Pediatric Cardiology 6/2010

01.08.2010 | Original Article

No Demonstrable Effect of Benzathine Penicillin on Recurrence of Rheumatic Fever in Pacific Island Population

verfasst von: Michael D. Seckeler, Tracey R. Hoke, Matthew J. Gurka, Leslie L. Barton

Erschienen in: Pediatric Cardiology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Compliance with secondary antibiotic prophylaxis for acute rheumatic fever (ARF) should decrease the rate of recurrence; however, efficacy in a highly endemic area has not been studied. A retrospective chart review of patients <21 years old with a diagnosis of ARF in the Northern Mariana Islands was performed. Patient compliance with benzathine penicillin G (BPG) prophylaxis was assessed. One hundred forty-four patients with ARF were identified and considered eligible, and the recurrence rate was 38%. Mean level of compliance with BPG was 59% in patients with no recurrence of ARF and 57% in patients with recurrence of ARF. Level of compliance was not shown to be associated with odds of recurrence. There was a trend toward significance (p = 0.06), with those patients who had carditis at the time of diagnosis of ARF having higher odds of recurrence. A remarkably high recurrence rate of ARF was found in this population, but there was no difference in compliance with secondary antibiotic prophylaxis between those with and without recurrence of ARF. These findings stress the need to improve methods of primary prevention and secondary antibiotic prophylaxis for ARF.
Literatur
1.
Zurück zum Zitat American Academy of Pediatrics (2006) Group A streptococcal infections. In: Pickering LK, Baker CJ, Long SS, McMillan J (eds) Red book: 2006 report of the Committee on Infectious Diseases, 27th edn. American Academy of Pediatrics, Elk Gove Village, pp 610–620 American Academy of Pediatrics (2006) Group A streptococcal infections. In: Pickering LK, Baker CJ, Long SS, McMillan J (eds) Red book: 2006 report of the Committee on Infectious Diseases, 27th edn. American Academy of Pediatrics, Elk Gove Village, pp 610–620
2.
Zurück zum Zitat Amir J, Ginat S, Cohen YH, Marcus TE, Keller N, Varsano I (1998) Lidocaine as a diluent for administration of benzathine penicillin G. Pediatr Infect Dis J 17:890–893CrossRefPubMed Amir J, Ginat S, Cohen YH, Marcus TE, Keller N, Varsano I (1998) Lidocaine as a diluent for administration of benzathine penicillin G. Pediatr Infect Dis J 17:890–893CrossRefPubMed
3.
Zurück zum Zitat Carapetis J, Robins-Browne R, Martin D, Shelby-James T, Hogg G (1995) Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. Clin Infect Dis 21:1220–1227PubMed Carapetis J, Robins-Browne R, Martin D, Shelby-James T, Hogg G (1995) Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. Clin Infect Dis 21:1220–1227PubMed
4.
Zurück zum Zitat Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685–694CrossRefPubMed Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685–694CrossRefPubMed
5.
Zurück zum Zitat Crum NF, Hale BR, Bradshaw DA, Malone JD, Chun HM, Gill WM et al (2003) Outbreak of group A streptococcal pneumonia among Marine Corps recruits―California, November 1–December 20, 2002. MMWR Morb Mortal Wkly Rep 52:106–109 Crum NF, Hale BR, Bradshaw DA, Malone JD, Chun HM, Gill WM et al (2003) Outbreak of group A streptococcal pneumonia among Marine Corps recruits―California, November 1–December 20, 2002. MMWR Morb Mortal Wkly Rep 52:106–109
6.
Zurück zum Zitat Currie BJ (1996) Are the currently recommended doses of benzathine penicillin G adequate for secondary prophylaxis of rheumatic fever? Pediatrics 97:989–991PubMed Currie BJ (1996) Are the currently recommended doses of benzathine penicillin G adequate for secondary prophylaxis of rheumatic fever? Pediatrics 97:989–991PubMed
7.
Zurück zum Zitat Eissa S, Lee R, Binns P, Garstone G, McDonald M (2005) Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community. Aust N Z J Public Health 29:521–525CrossRefPubMed Eissa S, Lee R, Binns P, Garstone G, McDonald M (2005) Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community. Aust N Z J Public Health 29:521–525CrossRefPubMed
8.
Zurück zum Zitat Erdem G, Mizumoto C, Esaki D, Abe L, Reddy V, Effler PV (2009) Streptococcal emm types in Hawaii: a region with high incidence of acute rheumatic fever. Pediatr Infect Dis J 28:13–16CrossRefPubMed Erdem G, Mizumoto C, Esaki D, Abe L, Reddy V, Effler PV (2009) Streptococcal emm types in Hawaii: a region with high incidence of acute rheumatic fever. Pediatr Infect Dis J 28:13–16CrossRefPubMed
9.
Zurück zum Zitat Gordis L, Markowitz M, Lilienfel AM (1969) Studies in epidemiology and preventability of rheumatic fever. IV. A quantitative determination of compliance in children on oral penicillin prophylaxis. Pediatrics 43:173–182PubMed Gordis L, Markowitz M, Lilienfel AM (1969) Studies in epidemiology and preventability of rheumatic fever. IV. A quantitative determination of compliance in children on oral penicillin prophylaxis. Pediatrics 43:173–182PubMed
10.
Zurück zum Zitat Grayson S, Horsburgh M, Lennon D (2006) An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme. N Z Med J 119:U2255PubMed Grayson S, Horsburgh M, Lennon D (2006) An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme. N Z Med J 119:U2255PubMed
11.
Zurück zum Zitat Harrington Z, Thomas DP, Currie BJ, Bulkanhawuy J (2006) Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med J Aust 184:514–517PubMed Harrington Z, Thomas DP, Currie BJ, Bulkanhawuy J (2006) Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med J Aust 184:514–517PubMed
12.
Zurück zum Zitat Hassell TA, Stuart KL (1974) Rheumatic fever prophylaxis: a three-year study. Br Med J 2:39–40CrossRefPubMed Hassell TA, Stuart KL (1974) Rheumatic fever prophylaxis: a three-year study. Br Med J 2:39–40CrossRefPubMed
13.
Zurück zum Zitat Lue HC, Wu MH, Wang JK, Fen-Fen W, Wu YN (1996) Three- versus four-week administration of benzathine penicillin G: effects on incidence of streptococcal infections and recurrences of rheumatic fever. Pediatrics 97:984–988PubMed Lue HC, Wu MH, Wang JK, Fen-Fen W, Wu YN (1996) Three- versus four-week administration of benzathine penicillin G: effects on incidence of streptococcal infections and recurrences of rheumatic fever. Pediatrics 97:984–988PubMed
14.
Zurück zum Zitat Martin JM, Barbadora KA (2006) Continued high caseload of rheumatic fever in western Pennsylvania: possible rheumatogenic emm types of streptococcus pyogenes. J Pediatr 149:58–63CrossRefPubMed Martin JM, Barbadora KA (2006) Continued high caseload of rheumatic fever in western Pennsylvania: possible rheumatogenic emm types of streptococcus pyogenes. J Pediatr 149:58–63CrossRefPubMed
15.
Zurück zum Zitat Meira ZMA, Goulart EMA, Colosimo EA, Mota CCC (2005) Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart 91:1019–1022CrossRefPubMed Meira ZMA, Goulart EMA, Colosimo EA, Mota CCC (2005) Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart 91:1019–1022CrossRefPubMed
16.
Zurück zum Zitat Seckeler MD, Barton LL, Brownstein R (2010) The persistent challenge of rheumatic fever in the Northern Mariana Islands. Int J Infect Dis 14:e226–e229CrossRefPubMed Seckeler MD, Barton LL, Brownstein R (2010) The persistent challenge of rheumatic fever in the Northern Mariana Islands. Int J Infect Dis 14:e226–e229CrossRefPubMed
17.
Zurück zum Zitat Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR (2009) Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 9:611–616CrossRefPubMed Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR (2009) Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 9:611–616CrossRefPubMed
18.
Zurück zum Zitat Stewart T, McDonald R, Currie B (2007) Acute rheumatic fever: adherence to secondary prophylaxis and follow up of indigenous patients in the Katherine region of the Northern Territory. Aust J Rural Health 15:234–240CrossRefPubMed Stewart T, McDonald R, Currie B (2007) Acute rheumatic fever: adherence to secondary prophylaxis and follow up of indigenous patients in the Katherine region of the Northern Territory. Aust J Rural Health 15:234–240CrossRefPubMed
19.
Zurück zum Zitat Stollerman GH, Dale JB (2008) The importance of the group A streptococcus capsule in the pathogenesis of human infections: a historical perspective. Clin Infect Dis 46:1038–1045CrossRefPubMed Stollerman GH, Dale JB (2008) The importance of the group A streptococcus capsule in the pathogenesis of human infections: a historical perspective. Clin Infect Dis 46:1038–1045CrossRefPubMed
20.
Zurück zum Zitat Stollerman GH, Rusoff JH (1952) Prophylaxis against group A streptococcal infections in rheumatic fever patients: use of new repository penicillin preparation. J Am Med Assoc 150:1571–1575PubMed Stollerman GH, Rusoff JH (1952) Prophylaxis against group A streptococcal infections in rheumatic fever patients: use of new repository penicillin preparation. J Am Med Assoc 150:1571–1575PubMed
21.
Zurück zum Zitat Stollerman GH, Rusoff JH, Hirschfeld I (1955) Prophylaxis against group A streptococci in rheumatic fever: the use of single monthly injections of benzathine penicillin G. N Engl J Med 252:787–792PubMedCrossRef Stollerman GH, Rusoff JH, Hirschfeld I (1955) Prophylaxis against group A streptococci in rheumatic fever: the use of single monthly injections of benzathine penicillin G. N Engl J Med 252:787–792PubMedCrossRef
22.
Zurück zum Zitat Veasy LG, Tani LY, Daly JA, Korgenski K, Miner L, Bale J et al (2004) Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 113:e168–e172CrossRefPubMed Veasy LG, Tani LY, Daly JA, Korgenski K, Miner L, Bale J et al (2004) Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 113:e168–e172CrossRefPubMed
23.
Zurück zum Zitat Walker KG, Human DG, DeMoor MMA, Sprenger KJ (1987) The problem of compliance in rheumatic fever. S Afr Med J 72:781–783PubMed Walker KG, Human DG, DeMoor MMA, Sprenger KJ (1987) The problem of compliance in rheumatic fever. S Afr Med J 72:781–783PubMed
24.
Zurück zum Zitat Wolfe RR (2000) Incidence of acute rheumatic fever: a persistent dilemma [letter]. Pediatrics 105:1375CrossRefPubMed Wolfe RR (2000) Incidence of acute rheumatic fever: a persistent dilemma [letter]. Pediatrics 105:1375CrossRefPubMed
Metadaten
Titel
No Demonstrable Effect of Benzathine Penicillin on Recurrence of Rheumatic Fever in Pacific Island Population
verfasst von
Michael D. Seckeler
Tracey R. Hoke
Matthew J. Gurka
Leslie L. Barton
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
Pediatric Cardiology / Ausgabe 6/2010
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-010-9718-5

Weitere Artikel der Ausgabe 6/2010

Pediatric Cardiology 6/2010 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.